百奥赛图(北京)医药科技股份有限公司（股票代码：02315，简称“百奥赛图-B”）于2026年4月9日发布2026年3月股份变动月报表，报告期为2026年3月。公告显示，公司在本月未发生任何新增股份发行、回购或注销事项，整体股本维持不变。
百奥赛图(北京)医药科技股份有限公司的注册股本合计为446,898,420股。其中，H股注册数量为110,781,920股，A股注册数量为336,116,500股，两类股份在报告期内均无增减变动。公告同时确认公司已符合香港联交所相关公众持股量要求。
报告显示，期权及其他激励计划在本月无任何新增授出、行使或失效情况；亦无额外购回及注销信息披露。公司表示将继续遵守香港联交所《上市规则》以及相关法律法规规定。
本次月报由联席公司秘书王永亮签署。公告称，截至3月末，公司整体股份数无变化，股本结构保持稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.